Tuesday, February 05, 2019 by: Zoey Sky Tags: badcancer, badhealth, cancer causes, cancer progression, drug response, genes, genetic mutation, lung cancer (Natural News) Deadly lung cancers were found to be the result of multiple genetic changes, according to a study led by researchers from the University of San Francisco (UCSF). The UCSF team’s findings imply that new first-line combination therapies are necessary to treat the full array of mutations that can worsen a patient’s cancer and thwart drug resistance. Trever Bivona, M.D., Ph.D., a UCSF Medical Center oncologist, said, “Currently we treat patients as if different oncogene mutations are mutually exclusive. If you have an EGFR mutation we treat you with one class of drugs, and if you have a KRAS mutation we pick a different class of drugs. Now we see such mutations regularly coexist, and so we need to adapt our approach to treatment.” Lung cancer is currently the leading cause … [Read more...] about Cause of cancer found to be more complex than previously thought: Lung cancer results from gene mutations that appear to work together
Non small cell stage 4 lung cancer
Former Olympic hockey player says radon caused stage 4 four lung cancer
close Video Former Olympic hockey player on how she developed lung cancer from the radon levels in her home Research shows radon, an odorless gas that can seep into your home, is associated with lung cancer. 33-year-old Olympian Rachael Malmberg shares her story and awareness on how the high levels of radon in her family homes caused her to develop stage 4 lung cancer. It's the second leading cause of lung cancer. And you don't even know when it's present: radon. It’s an odorless tasteless gas that seeps up through the ground and diffuses into the air—and often times, right into your home. Rachael Malmberg, a former member of the U.S. Women’s ice hockey Olympic team had no idea her childhood and current home had dangerous levels of radon until it was too late, and she was diagnosed with stage 4 lung cancer. “It wasn't on my radar at all actually until I started doing research on causes of lung cancer. Upon diagnosis I had no idea about … [Read more...] about Former Olympic hockey player says radon caused stage 4 four lung cancer
Understanding Ruth Bader Ginsburg’s cancer surgery
(CNN)The Supreme Court announced Friday that Justice Ruth Bader Ginsburg had two cancerous nodules removed from her left lung's lower lobe in an operation known as a lobectomy. The nodules were discovered while Ginsburg, 85, was being evaluated and treated for a rib fracture due to a fall last month. What is a lobectomy? A lobectomy refers to the removal of a single lobe in the lung. The left lung has two lobes, whereas the right lung has three. Dr. Robert Miller, a professor of medicine at Vanderbilt University Medical Center who was not involved in Ginsburg's care, said a patient whose lungs are otherwise healthy "can recover from [a lobectomy] and not really notice significant impairment." Justice Ruth Bader Ginsburg has cancerous nodules removed from lung Read More Ginsburg's lobectomy was performed by Dr. Valerie Rusch, a thoracic surgeon at Memorial Sloan Kettering Cancer Center in New York City. According to her bio, Rusch "was among the first women in the … [Read more...] about Understanding Ruth Bader Ginsburg’s cancer surgery
AstraZeneca buoyed as Imfinzi cuts lung cancer deaths by a third
LONDON (Reuters) - AstraZeneca’s immunotherapy drug Imfinzi cut the risk of death in patients with mid-stage lung cancer by nearly a third in a closely watched clinical study, reinforcing the case for using the drug in earlier disease. A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble The encouraging overall survival data boosts prospects for a medicine that was approved this week in Europe and has already had a promising U.S. commercial launch, based on its ability to slow disease progression. As the leading cause of cancer deaths, lung cancer represents the biggest opportunity for companies seeking to exploit the power of modern cancer immunotherapies. Deutsche Bank analysts said the “impressive” results would cement Imfinzi as the standard of care for lung cancer patients whose disease has not yet spread widely. Until now, the five-year survival rate for such patients has been around 15 percent. … [Read more...] about AstraZeneca buoyed as Imfinzi cuts lung cancer deaths by a third
AstraZeneca immunotherapy drug cuts lung cancer deaths by almost a…
LONDON (Reuters) - AstraZeneca’s immunotherapy drug Imfinzi cut the risk of death in patients with mid-stage lung cancer by nearly a third in a closely watched clinical study, reinforcing the case for using the drug in earlier disease. A sign is seen at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble The encouraging overall survival data boost prospects for a medicine that was approved this week in Europe and has already had a promising U.S. commercial launch, based on its ability to slow disease progression. As the leading cause of cancer deaths, lung cancer represents the biggest opportunity for companies seeking to exploit the power of modern cancer immunotherapies. AstraZeneca’s oncology business head David Fredrickson told Reuters the findings would be “important” in driving uptake of the medicine, which he expects to be launched in 40 markets by the end of the year. Although AstraZeneca announced in May … [Read more...] about AstraZeneca immunotherapy drug cuts lung cancer deaths by almost a…